WORLD HEALTH ORGANIZATION

The global anti-obesity medication market hit $6 billion annually and could grow to $100 billion by 2030, driven by rising obesity rates and new effective drugs like GLP-1 receptor agonists. Eli Lilly and Novo Nordisk lead, with the market's growth sensitive to insurance, drug pricing, and patient use duration.

The Johns Hopkins Center for Health Security welcomed 30 diverse professionals into its 2022 Emerging Leaders in Biosecurity Initiative, marking the most diverse class in program history. Fellows will engage in workshops and networking to enhance biosecurity leadership and expertise, supported by the Open Philanthropy Project.

80% of the world's population relies on traditional medicine due to accessibility and cost. The WHO and India hosted a summit to share best practices and scientific evidence on traditional medicine, aiming to integrate it into national health systems. Traditional medicine, including acupuncture, shows benefits but requires more research for safety and efficacy. The WHO is developing standards to make traditional medicine safer and more accessible globally.

Sarcomas, including Ewing sarcoma (ES), are aggressive tumors originating from mesenchymal cells. ES, primarily affecting children and young adults, is characterized by the EWS-FLI1 fusion protein, crucial for its development. Diagnosis involves imaging and molecular analysis, with treatment combining chemotherapy, surgery, and radiation. Research focuses on targeted therapies, including EWS-FLI1 inhibition, to improve outcomes.

IPG Health launched a pioneering multidisciplinary offering to enhance diversity in clinical trials, addressing underrepresentation across race, gender, age, and intersectional groups. This initiative leverages IPG Health's expertise in medical strategy, data analytics, and patient engagement to overcome barriers in clinical trial participation, aiming for more inclusive treatment innovations and health equity.

A study in PLOS One found dementia in one spouse reduces divorce likelihood, contrasting with higher divorce rates among those with behavioral issues like aggression. Analyzing data from 37 U.S. Alzheimer’s centers, it highlighted dementia's strain on relationships, emphasizing the need for treating symptoms to improve life quality for patients and their families.

NHS care quality has declined due to austerity, with longer waits and reduced preventive care. Key areas like A&E, surgery, and child health are worsening, risking future health crises. Despite some improvements, the pandemic exacerbated pre-existing issues, highlighting the need for increased funding and staff.

The Center for Health Security (CHS) at Johns Hopkins University focuses on reducing biological risks, including Global Catastrophic Biological Risks (GCBRs), through research, policy advocacy, and education. It emphasizes the importance of pandemic preparedness, biosecurity, and the development of medical countermeasures. CHS has played a significant role in COVID-19 response and continues to work on improving international biosafety norms and vaccine development for future pathogens.

Research highlights the significant impact of social engagement and loneliness on dementia risk, emphasizing the protective role of cognitive and social activities. Studies suggest that social isolation and loneliness are associated with increased dementia risk, while active social participation and cognitive leisure activities may mitigate this risk. The importance of addressing modifiable risk factors for dementia prevention is underscored.

Employers are increasingly focusing on women's reproductive health, including fertility, menopause, and abortion access. Post-Dobbs decision, some have worked to ensure abortion coverage, but state laws vary, complicating compliance. The FDA's approval of Mifepristone for medication abortion faces legal challenges, potentially restricting access nationwide. Employers may need to adjust health plans and support services accordingly.